Background illustration for clinical trials search

Paid Clinical Trials Brockton

Discover 3,069 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression

for
Treatment Resistant Depression (TRD)
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT07563868

Recruiting

Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

for
Major Depression
Location: Belmont MA
Sponsor: Mclean Hospital

Sex: All

Age: 18+

Code: NCT07560878

Early_phase1, Recruiting

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

for
Melanoma, Squamous Cell Carcinoma of Head and Neck
Location: Boston MA, New Haven CT, Richmond VA
Sponsor: IO Biotech

Sex: All

Age: 18+

Code: NCT05280314

Phase2, Recruiting

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

for
Advanced Malignant Solid Neoplasm,
Location: Boston MA, New Haven CT, Trumbull CT, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06311214

Phase2, Recruiting

Avo In R/R And Previously Untreated MCL

for
Mantle Cell Lymphoma, Refractory Lymphoma
Location: Boston MA, Chicago IL
Sponsor: Austin I Kim

Sex: All

Age: 18+

Code: NCT04855695

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Boston MA, Nashville TN, Peoria IL
Sponsor: Nerviano Medical Sciences

Sex: All

Age: 18+

Code: NCT06931626

Phase1, Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

for
KRAS Altered Advanced or Metastatic Solid Tumors
Location: Boston MA, Philadelphia PA, Montreal, Fairfax VA,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07094113

Phase1, Recruiting

SURGE: Supporting Utility and Representation in Genomics-based Cancer Trial Enrollment (Intervention)

for
Gastrointestinal Cancer, Hematologic Cancer, Thoracic Cancer
Location: Boston MA, Brighton MA
Sponsor: Nadine Jackson, MD, MPH

Sex: All

Age: 18+

Code: NCT05375643

Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

for
Advanced Solid Tumor
Location: Boston MA, Hartford CT, New Haven CT, New York NY,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07070232

Phase1, Phase2, Recruiting

ELEVATE-HFpEF Clinical Study

for
Heart Failure With Preserved Ejection Fraction (HFpEF)
Location: Boston MA, Hartford CT, Burlington VT, Wynnewood PA,
Sponsor: Medtronic Cardiac Rhythm and Heart Failure

Sex: All

Age: 40+

Code: NCT06678841

Recruiting

A Study of PHN-012 in Patients With Advanced Solid Tumors

for
Colon Cancer, Pancreatic Cancer, Lung Cancer (NSCLC),
Location: Boston MA, Washington D.C. DC, Fairfax VA, Durham NC,
Sponsor: Pheon Therapeutics

Sex: All

Age: 18+

Code: NCT07127874

Phase1, Recruiting

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

for
T-Cell Lymphoma
Location: Boston MA, New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT05313243

Phase2, Recruiting

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Boston MA, New York NY, Hackensack NJ, Buffalo NY,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06121843

Phase1, Recruiting

Ph 2 Elacestrant in ER Positive Uterine Sarcomas

for
Uterine Sarcoma, Uterine Leiomyosarcoma,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: Female

Age: 18+

Code: NCT07467772

Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

for
Narcolepsy Type 1
Location: Newton MA, Middletown NJ, Wyomissing PA, Toronto,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT07455383

Phase3, Recruiting

Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension (PAH)
Location: Boston MA, Cincinnati OH, Omaha NE, Aurora CO
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07318597

Phase2, Recruiting

A Study of PT0253 in Participants With KRAS G12D Mutated Advanced Solid Tumors

for
Solid Tumor
Location: Boston MA, Fairfax VA, Grand Rapids MI, San Antonio TX,
Sponsor: PAQ Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06797336

Phase1, Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

for
Narcolepsy Type 2
Location: Newton MA, Wyomissing PA, Toronto, Markham, Novi MI,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT07502443

Phase3, Recruiting

A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma, Relapse Multiple Myeloma,
Location: Boston MA
Sponsor: David Avigan

Sex: All

Age: 18+

Code: NCT06799026

Phase1, Recruiting

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

for
Plaque Psoriasis
Location: Milford MA, Philadelphia PA, Rockville MD, Toronto,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 12 - 17

Code: NCT06979453

Phase3, Recruiting